Cite

HARVARD Citation

    Lau, A. et al. (2014). Evaluation of response to first-line treatment for chronic myeloid leukemia: has imatinib been outperformed?. International journal of hematologic oncology. pp. 153-168. [Online]. 
  
Back to record